Skip to main content

SARS-CoV-2 Vaccine Does Not Increase New-Onset Seizure Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on April 30, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, April 30, 2024 -- There is no risk for new-onset seizure incidence for individuals receiving a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine versus placebo, according to a review published online April 29 in JAMA Neurology.

Ali Rafati, M.D., from Iran University of Medical Sciences in Tehran, and colleagues conducted a systematic literature review to identify studies examining seizure incidence among SARS-CoV-2 vaccine recipients versus those receiving placebo.

Based on six randomized clinical trials (63,521 vaccine and 54,919 placebo recipients), the researchers found that during a 28-day follow-up after injection, there was no statistically significant difference between the groups (nine events in vaccine recipients [0.014 percent] and one event in placebo recipients [0.002 percent]; odds ratio, 2.70; 95 percent confidence interval, 0.76 to 9.57; P = 0.12). Similarly, when examining the entire blinded-phase period after injection (median >43 days), there were no significant differences identified for incident new-onset seizure (0.03 percent in vaccine recipients and 0.012 percent in placebo recipients; odds ratio, 2.31; 95 percent confidence interval, 0.86 to 3.23; P > 0.99).

"Since the inflammatory response induced by SARS-CoV-2 infection is probably more prolonged and severe than the SARS-CoV-2 vaccines, the adverse events would be more prevalent and critical; however, it has to be confirmed by future studies," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Further Support and Information on COVID-19

Read this next

Higher COVID-19 Vaccination Rates Tied to Decrease in Childhood Asthma Symptoms

WEDNESDAY, July 3, 2024 -- Higher COVID-19 vaccination rates are associated with a lower prevalence of parent-reported childhood asthma symptoms, according to a research letter...

COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes

TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...

Cannabis Use Tied to Risk of COVID-19 Hospitalizations, ICU Admissions

TUESDAY, June 25, 2024 -- Current cannabis use may be an independent risk factor for COVID-19–related complications, according to a study published online June 21...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.